Cannabis Painkillers Going to be Tough Sell to FDA
Cannabis painkillers seem like the next logical step for the pharmaceutical industry considering marijuana’s popularity and the opioid crisis. However, no matter how much big pharma wants in on the booming cannabis business they need to contend with the schedule 1 federal classification of the plant which means the FDA is unlikely to approve as things stand now. Ever since […]
Read more